U.S. Online Retail and Ecommerce Stock News

If you are wondering whether Sterling Infrastructure at US$532.67 is priced for perfection or still offers value, this article walks through the numbers in plain English. The stock has delivered returns of 7.1% over the last 7 days, 27.9% over 30 days, 66.9% year to date and 221.6% over 1 year, with a very large 3 year and 5 year gain that is well above 7x. Recent coverage has focused on Sterling Infrastructure's role in capital goods and construction projects across the US, as investors...

Sanmina (SANM) just reported quarterly results that came in ahead of analyst expectations for both revenue and earnings, supported by demand from the ZT Systems business and core operations, and accompanied by higher full-year guidance. See our latest analysis for Sanmina. The strong earnings beat, higher guidance and fresh US$600m buyback authorization have been reflected in a sharp 71.5% 1 month share price return and a very large 1 year total shareholder return of 178.3%, pointing to...

In April 2026, Amneal Pharmaceuticals reported positive interim Phase 4 ELEVATE-PD data showing CREXONT delivered improved “Good On” time, reduced “Off” time and better motor control for Parkinson’s patients, while reaffirming its full-year 2026 revenue outlook at US$3.05 billion to US$3.15 billion. These results support Amneal’s push into higher-value specialty neurology treatments, potentially enhancing the role of CREXONT within its broader branded portfolio. Next, we’ll examine how...

Eli Lilly (LLY) has jumped back into the spotlight after its first quarter 2026 report, as strong GLP‑1 demand and fresh FDA approvals led management to lift full year revenue and profit guidance. See our latest analysis for Eli Lilly. The share price reaction around the earnings beat and guidance raise has been positive in the very near term, with a 1 day share price return of 3.07% and 7 day share price return of 8.98%. However, the 90 day share price return of 7.74% and year to date share...

In recent months, Alvotech announced that longtime General Counsel Tanya Zharov will step down after six years, with a multi‑month transition as incoming executive Lisa Graver assumes expanded leadership responsibilities and several senior leaders relocate to Reykjavik. This combination of legal leadership change and management team relocation could influence how Alvotech manages regulatory risk, governance, and future corporate decision‑making. We’ll now examine how Graver’s expanded...

Stagwell (STGW) has attracted fresh attention after recent returns and financial figures highlighted its performance in the marketing and digital transformation space. This provides investors with an updated snapshot of growth, profitability, and current market pricing. See our latest analysis for Stagwell. Stagwell’s share price has held at US$6.36 after a mixed short term pattern, with a 1 day share price return of 1.44% and a 7 day share price return showing a 7.15% decline, while the year...

Investors may be wondering whether Axon Enterprise is attractively priced at around US$402 per share, or if the recent excitement has already been accounted for in the stock price. The share price recently closed at US$402.31, with a 1.3% gain over 7 days, a 2.5% decline over 30 days, and returns of a 28.6% decline year to date and a 36.0% decline over 1 year, set against longer term gains of 82.9% over 3 years and 198.6% over 5 years. These mixed returns have put valuation questions back on...

In late April 2026, Zimmer Biomet Holdings reported first-quarter 2026 results showing sales of US$2,086.7 million and net income of US$238.1 million, reaffirmed its full-year revenue growth guidance, detailed ongoing share repurchases totaling US$1.48 billion since 2024, and announced the departure of its CFO, with the Controller and Chief Accounting Officer appointed as interim CFO. The combination of stronger earnings, benefits from technology platforms and tariffs, continued buybacks,...

Pacira BioSciences, Inc. recently reported first-quarter 2026 results showing revenue of US$177.38 million, up from US$168.92 million a year earlier, while net income eased to US$2.92 million and diluted EPS to US$0.07. Alongside these results, the company highlighted real-world Medicare data for EXPAREL showing reduced opioid use and medical costs after outpatient hip replacements, while an activist proxy battle with DOMA Perpetual Capital Management adds a governance twist ahead of the...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Hess...

Equinix (NasdaqGS:EQIX) has agreed to acquire Nordic data center operator atNorth, expanding its presence and capacity in the region. The company announced a new partnership with SpinLaunch to host globally distributed teleports in Equinix data centers. The SpinLaunch partnership is expected to support the Meridian Space satellite constellation for worldwide data connectivity. For investors tracking digital infrastructure, Equinix sits at the intersection of data centers, cloud...

It looks like First Bank ( NASDAQ:FRBA ) is about to go ex-dividend in the next four days. Typically, the ex-dividend...

Some First Financial Bancorp. ( NASDAQ:FFBC ) shareholders may be a little concerned to see that the Chairman of the...

Anyone interested in Pathward Financial, Inc. ( NASDAQ:CASH ) should probably be aware that the Independent Director...

We wouldn't blame Adobe Inc. ( NASDAQ:ADBE ) shareholders if they were a little worried about the fact that Shantanu...

Universal Insurance Holdings, Inc. ( NYSE:UVE ) is about to trade ex-dividend in the next four days. The ex-dividend...

Timken (NYSE:TKR) agreed to sell its belts business to Gates Industrial in a transaction expected to close in the third quarter. The deal is intended to sharpen Timken’s focus on core operations and support margin improvement in its Industrial Motion segment. Transaction proceeds are planned to fund Timken’s broader capital allocation priorities. For you as an investor, this move sits at the intersection of two industrial names that both operate across power transmission and motion control...

For investors considering whether Intuitive Surgical at around US$457.78 is a fair deal, expensive, or potentially mispriced, this article walks through key clues in the valuation story. The stock has seen mixed recent returns, with a 5.1% decline over the last 7 days, a 1.3% gain over the last 30 days, and year to date and 1 year returns of 18.5% and 13.5% declines, while the 3 and 5 year returns sit at 50.2% and 60.2% respectively. Recent coverage has continued to focus on Intuitive...

Wondering if Acadia Healthcare Company at around US$27.85 is a bargain or a value trap? This article walks through what the current price might be implying. The stock has returned 1.7% over the past week, 16.2% over the last month, 94.9% year to date and 19.5% over the past year, while the 3 year and 5 year returns of 59.7% and 56.5% declines show that longer term holders have had a very different experience. Recent coverage has focused on Acadia Healthcare Company as a specialist in...

What the Wrigley Field deal means for Shift4 Payments stock Shift4 Payments (FOUR) is in focus after agreeing to power payments across Wrigley Field for the Chicago Cubs, extending its integrated commerce ecosystem across concessions, retail outlets, and the adjacent Gallagher Way district. For investors, this high profile venue win sits alongside an existing roster of major sports and entertainment clients, raising questions about how much value these contracts might add relative to the...

This article examines whether Bel Fuse at around US$256.12 is still offering value or if most of the opportunity has already played out, and breaks down what the current price might be indicating. The stock has posted returns of 1.3% over 7 days, 36.2% over 30 days, 67.5% year to date and 300.3% over the past year, with a very large 5 year gain of 1,382.4% that puts recent moves into a longer-term context. Recent coverage has focused on Bel Fuse's share price performance and how investors...

Azenta has appointed Trey (William E.) Martin III as President of its Multiomics business, with former president Ginger Zhou remaining as an advisor through November 2026, and granted him 17,790 time-vested RSUs that will vest in equal annual tranches from April 2027 to April 2029. This leadership transition in a core growth area, coupled with equity-based incentives, signals how Azenta is aligning executive oversight and compensation with its long-range Multiomics ambitions. Next, we’ll...

International Paper Company has already reported first-quarter 2026 results, with sales rising to US$5,971 million from US$5,264 million and net income improving to US$60 million from a net loss of US$105 million a year earlier. The quarter also marked progress on its portfolio reshaping, with management highlighting transformation spending, mill reliability efforts, and acquisitions such as North Pacific Paper Company and the Norpak mill as building blocks for its longer-term plan to...

Waste Connections (WCN) shares were in focus after first quarter 2026 results topped expectations, with management reaffirming full year guidance and pointing to benefits from solid waste pricing, special waste volumes, and AI driven pricing tools. See our latest analysis for Waste Connections. Despite the upbeat first quarter, the recent share price has been weaker, with a 30 day share price return of 2.92% and a year to date share price return of 7.40%. The 1 year total shareholder return...